This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
FederalRegister.gov retrieves relevant information about this document from Regulations.gov to provide users with additional context. This information is not part of the official Federal Register document.
Environmental Protection Agency (EPA).
Notice.
EPA is required under the Toxic Substances Control Act (TSCA) to make information publicly available and to publish information in the Federal Register pertaining to submissions under TSCA, including notice of receipt of a Premanufacture notice (PMN), Significant New Use Notice (SNUN) or Microbial Commercial Activity Notice (MCAN), including an amended notice or test information; an exemption application (Biotech exemption); an application for a test marketing exemption (TME), both pending and/or concluded; a notice of commencement (NOC) of manufacture (including import) for new chemical substances; and a periodic status report on new chemical substances that are currently under EPA review or have recently concluded review. This document covers the period from 10/01/2021 to 10/31/2021.
Comments identified by the specific case number provided in this document must be received on or before December 22, 2021.
Submit your comments, identified by docket identification (ID) number EPA-HQ-OPPT-2021-0068, and the specific case number for the chemical substance related to your comment, through the Federal eRulemaking Portal at http://www.regulations.gov. Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. Additional instructions on commenting or visiting the docket, along with more information about dockets generally, is available at http://www.epa.gov/dockets.
Due to the public health concerns related to COVID-19, the EPA Docket Center (EPA/DC) and Reading Room is closed to visitors with limited exceptions. The staff continues to provide remote customer service via email, phone, and webform. For the latest status information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.
For technical information contact: Jim Rahai, Project Management and Operations Division (MC 7407M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number: (202) 564-8593; email address: rahai.jim@epa.gov.
For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554-1404; email address: TSCA-Hotline@epa.gov.
This document provides the receipt and status reports for the period from 10/01/2021 to 10/31/2021. The Agency is providing notice of receipt of PMNs, SNUNs and MCANs (including amended notices and test information); ( printed page 66297) an exemption application under 40 CFR part 725 (Biotech exemption); TMEs, both pending and/or concluded; NOCs to manufacture a new chemical substance; and a periodic status report on new chemical substances that are currently under EPA review or have recently concluded review.
EPA is also providing information on its website about cases reviewed under the amended TSCA, including the section 5 PMN/SNUN/MCAN and exemption notices received, the date of receipt, the final EPA determination on the notice, and the effective date of EPA's determination for PMN/SNUN/MCAN notices on its website at: https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/status-pre-manufacture-notices. This information is updated on a weekly basis.
Under the Toxic Substances Control Act (TSCA), 15 U.S.C. 2601 et seq., a chemical substance may be either an “existing” chemical substance or a “new” chemical substance. Any chemical substance that is not on EPA's TSCA Inventory of Chemical Substances (TSCA Inventory) is classified as a “new chemical substance,” while a chemical substance that is listed on the TSCA Inventory is classified as an “existing chemical substance.” (See TSCA section 3(11).) For more information about the TSCA Inventory please go to: https://www.epa.gov/tsca-inventory.
Any person who intends to manufacture (including import) a new chemical substance for a non-exempt commercial purpose, or to manufacture or process a chemical substance in a non-exempt manner for a use that EPA has determined is a significant new use, is required by TSCA section 5 to provide EPA with a PMN, MCAN or SNUN, as appropriate, before initiating the activity. EPA will review the notice, make a risk determination on the chemical substance or significant new use, and take appropriate action as described in TSCA section 5(a)(3).
TSCA section 5(h)(1) authorizes EPA to allow persons, upon application and under appropriate restrictions, to manufacture or process a new chemical substance, or a chemical substance subject to a significant new use rule (SNUR) issued under TSCA section 5(a)(2), for “test marketing” purposes, upon a showing that the manufacture, processing, distribution in commerce, use, and disposal of the chemical will not present an unreasonable risk of injury to health or the environment. This is referred to as a test marketing exemption, or TME. For more information about the requirements applicable to a new chemical go to: http://www.epa.gov/oppt/newchems.
Under TSCA sections 5 and 8 and EPA regulations, EPA is required to publish in the Federal Register certain information, including notice of receipt of a PMN/SNUN/MCAN (including amended notices and test information); an exemption application under 40 CFR part 725 (biotech exemption); an application for a TME, both pending and concluded; NOCs to manufacture a new chemical substance; and a periodic status report on the new chemical substances that are currently under EPA review or have recently concluded review.
This action provides information that is directed to the public in general.
No.
1. Submitting confidential business information (CBI). Do not submit this information to EPA through regulations.gov or email. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as CBI and then identify electronically within the disk or CD-ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2.
2. Tips for preparing your comments. When preparing and submitting your comments, see the commenting tips at http://www.epa.gov/dockets/comments.html.
Given public interest in information on the status of TSCA section 5 cases under EPA review and, in particular, the final determination of such cases, has increased. In an effort to be responsive to the regulated community, the users of this information, and the general public, to comply with the requirements of TSCA, to conserve EPA resources and to streamline the process and make it more timely, EPA is providing information on its website about cases reviewed under the amended TSCA, including the TSCA section 5 PMN/SNUN/MCAN and exemption notices received, the date of receipt, the final EPA determination on the notice, and the effective date of EPA's determination for PMN/SNUN/MCAN notices on its website at: https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/status-pre-manufacture-notices. This information is updated on a weekly basis.
For the PMN/SNUN/MCANs that have passed an initial screening by EPA during this period, Table I provides the following information (to the extent that such information is not subject to a CBI claim) on the notices screened by EPA during this period: The EPA case number assigned to the notice that indicates whether the submission is an initial submission, or an amendment, a notation of which version was received, the date the notice was received by EPA, the submitting manufacturer ( i.e., domestic producer or importer), the potential uses identified by the manufacturer in the notice, and the chemical substance identity.
As used in each of the tables in this unit, (S) indicates that the information in the table is the specific information provided by the submitter, and (G) indicates that this information in the table is generic information because the specific information provided by the submitter was claimed as CBI. Submissions which are initial submissions will not have a letter following the case number. Submissions which are amendments to previous submissions will have a case number followed by the letter “A” ( e.g., P-18-1234A). The version column designates submissions in sequence as “1”, “2”, “3”, etc. Note that in some cases, an initial submission is not numbered as version 1; this is because earlier version(s) were rejected as incomplete or invalid submissions. Note also that future versions of the following tables may adjust slightly as the Agency works to automate population of the data in the tables. ( printed page 66298)
| Case No. | Version | Received date | Manufacturer | Use | Chemical substance |
|---|---|---|---|---|---|
| P-18-0273A | 8 | 10/06/2021 | CBI | (G) Used in polymer manufacturing | (S) 1,4-Cyclohexanedicarboxylic acid, 1,4-bis(2-ethylhexyl) ester |
| P-21-0137 | 5 | 10/22/2021 | Lamberti USA Inc | (G) Industrial additive | (G) Triazine-trione, tris(isocyanatoalkyl)-, polymer with substituted diisocyanato alkylcarbomonocycle, hydro-hydroxypoly(oxyalkanediyl)and hydro-hydroxypoly[oxy(alkyl-alkanediyl)], aliphatic alkyl amine-blocked |
| P-21-0181A | 4 | 10/25/2021 | CBI | (G) Color developer | (G) 1,3-Benzenedicarboxamide, N1,N3-bis(carbomonocyclic)-5-[[(carbomonocyclic)amino]sulfonyl]- |
| P-21-0201A | 7 | 10/13/2021 | The Lewis Chemical Company | (S) The intention is for this product to be used as an offset to N,N,N′,N′,N″-Pentamethyl-N-tallow alkyl1,3-propanediammonium chloride (CAS #68607-29-4) in a cationic latex asphalt emulsion formulation | (S) 1,3-Propanediaminium, 2-hydroxy-N1,N1,N1,N3,N3-pentamethyl-N3-9-octadecen-1-yl, chloride (1:2); (S) 1,3-Propanediaminium, 2-hydroxy-N1,N1,N1,N3,N3-pentamethyl-N3-octadecyl-, chloride (1:2);(S) 1,3-Propanediaminium, 2-hydroxy-N1,N1,N1,N3,N3-pentamethyl-N3-tetradecyl-, chloride (1:2); (S) 1,3-Propanediaminium, N-hexadecyl-2-hydroxy-N,N,N′,N′,N′-pentamethyl-, dichloride (2CI); |
| P-21-0207A | 5 | 10/21/2021 | CBI | (G) Emulsifier | (G) Carboxy ether; branched and linear ethercarboxylate; |
| P-21-0211A | 4 | 10/01/2021 | CBI | (G) Process aid | (G) Polycyclic Dioxolane. |
| P-21-0211A | 5 | 10/21/2021 | CBI | (G) Process aid | (G) Polycyclic Dioxolane. |
| SN-22-0001 | 1 | 10/06/2021 | CBI | (G) Component in polishing formulation | (S) Ethanol, 2,2′,2″-nitrilotris-, compd. with .alpha.-[2,4,6-tris(1-phenylethyl)phenyl]-.omega.-hydroxypoly(oxy-1,2-ethanediyl) phosphate |
| * The term `Approved' indicates that a submission has passed a quick initial screen ensuring all required information and documents have been provided with the submission prior to the start of the 90 day review period, and in no way reflects the final status of a complete submission review. | |||||
In Table II of this unit, EPA provides the following information (to the extent that such information is not claimed as CBI) on the NOCs that have passed an initial screening by EPA during this period: The EPA case number assigned to the NOC including whether the submission was an initial or amended submission, the date the NOC was received by EPA, the date of commencement provided by the submitter in the NOC, a notation of the type of amendment ( e.g., amendment to generic name, specific name, technical contact information, etc.) and chemical substance identity.
| Case No. | Received date | Commencement date | If Amendment, type of amendment | Chemical substance |
|---|---|---|---|---|
| J-20-0022 | 10/07/2021 | 10/06/2021 | N | (G) Modified saccharomyces cerevisiae. |
| P-15-0607A | 10/27/2021 | 07/26/2021 | Withdrew CBI claim | (S) 1,2,4,5,7,8-hexoxonane, 3,6,9-trimethyl-, 3,6,9-tris(et and pr)derivs. |
| P-18-0023 | 10/13/2021 | 09/30/2021 | N | (G) Propanediol phosphate. |
| P-18-0024 | 10/06/2021 | 10/06/2021 | N | (G) Phosphate epichlorohydrin polymer. |
| P-18-0073 | 10/13/2021 | 10/11/2021 | N | (S) Sulfuric acid, ammonium salt (1:?). |
| P-19-0098 | 09/30/2021 | 09/15/2021 | N | (G) Phosphoric acid, polymer with (hydroxyalkyl)-alkanediol and alkanediol. |
| P-19-0098A | 10/25/2021 | 09/15/2021 | Withdrew CBI claim | (S) Phosphoric acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol and 1,2-ethanediol. |
| P-21-0095 | 10/04/2021 | 09/30/2021 | N | (S) 1-tetradecene, homopolymer, hydrogenated, by-products from, c28-42 fraction. |
| P-21-0125 | 10/14/2021 | 09/23/2021 | N | (S) Nonane, branched. |
| P-96-1181 | 10/14/2021 | 10/12/2021 | N | (G) Inorganic acid, compds. with [(substituted-propyl)imino]bis[alkanol]-bisphenol a-epichlorohydrin-hexahydro-1,3-isobenzofurandione-polyethylene glycol ether with bisphenol a (2:1) polymer-alkanolamine reaction products. |
| P-98-0179 | 10/26/2021 | 10/07/2021 | N | (G) Trialkoxysilylalkylamino-alkyldioate. |
| * The term `Approved' indicates that a submission has passed a quick initial screen ensuring all required information and documents have been provided with the submission. | ||||
In Table III of this unit, EPA provides the following information (to the extent such information is not subject to a CBI claim) on the test information that has been received during this time period: The EPA case number assigned to the test information; the date the test information was received by EPA, the type of test information submitted, and chemical substance identity.
| Case No. | Received date | Type of test information | Chemical substance |
|---|---|---|---|
| P-14-0712 | 10/11/2021 | Quarterly PCDD/F Test of PMN Substance using EPA Test Method 8290A | (G) Plastics, wastes, pyrolyzed, bulk pyrolysate. |
| P-16-0150 | 10/19/2021 | 96-Hour Static Toxicity Test with Marine Diatom (Skeletonema Costatum), 96-Hour Static Acute Toxicity Test with Sheepshead Minnow (Cyprinodon Variegatus), and 96-Hour Static Acute Toxicity Test with Saltwater Mysid (Americamysis Bahia) | (G) Chlorofluorocarbon. |
| ( printed page 66299) | |||
| P-18-0016 | 10/12/2021 | Notice of Study Schedule | (G) Aromatic sulfonium tricyclo fluoroalkyl sulfonic acid salt. |
| P-18-0124 | 10/01/2021 | Draft Protocols for a 90-Day Inhalation Toxicity Study of Lithium Nickel Potassium Oxide (KDLNO) in Sprague Dawley Rats with 8-Week Recovery Period and a 4-Week Inhalation Toxicity Study of Lithium Nickel Potassium Oxide (KDLNO) in Sprague Dawley Rats with a 2-Week Recovery | (G) Alkali nickel oxide. |
| P-20-0014 | 10/21/2021 | Fish Acute Toxicity Mitigated by Humic Acid (OCSPP Test Guidelines 850.1085) | (G) Sugars, polymer with alkanetriamine. |
| P-20-0042 | 10/12/2021 | Notice of Study Schedule | (G) Sulfonium, trisaryl-, 7,7-dialkyl-2-heteropolycyclic -1-alkanesulfonic acid (1:1). |
| P-20-0174 | 09/30/2021 | Partition Coefficient ( n -Octanol/Water) Estimation by Liquid Chromatography (Test Guidelines OCSPP 830.7570) | (S) 6-octen-1-ol, 3,7-dimethyl-, homopolymer, monoacetate. |
| P-20-0184 | 09/30/2021 | Partition Coefficient ( n -Octanol/Water) Estimation by Liquid Chromatography (Test Guidelines OCSPP 830.7570) and Partition Coefficient (n-octanol/water) HPLC Method (Test Guidelines OECD 117) | (S) 6-octen-1-ol, 3,7-dimethyl-, homopolymer. |
If you are interested in information that is not included in these tables, you may contact EPA's technical information contact or general information contact as described under FOR FURTHER INFORMATION CONTACT to access additional non-CBI information that may be available.
Authority:15 U.S.C. 2601 et seq.
Dated: November 9, 2021.
Pamela Myrick,
Director, Project Management and Operations Division, Office of Pollution Prevention and Toxics.
[FR Doc. 2021-25422 Filed 11-19-21; 8:45 am]
BILLING CODE 6560-50-P